CO2020009424A2 - Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas - Google Patents

Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas

Info

Publication number
CO2020009424A2
CO2020009424A2 CONC2020/0009424A CO2020009424A CO2020009424A2 CO 2020009424 A2 CO2020009424 A2 CO 2020009424A2 CO 2020009424 A CO2020009424 A CO 2020009424A CO 2020009424 A2 CO2020009424 A2 CO 2020009424A2
Authority
CO
Colombia
Prior art keywords
otitis
prevention
treatment
composition
upper respiratory
Prior art date
Application number
CONC2020/0009424A
Other languages
English (en)
Inventor
Quintana Esther Antonia Jiménez
Gómez Juan Miguel Rodríguez
Original Assignee
Probisearch S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probisearch S L U filed Critical Probisearch S L U
Publication of CO2020009424A2 publication Critical patent/CO2020009424A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/181—Salivarius
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Una cepa de Lactobacillus salivarius como producto probiótico, y su uso en el tratamiento y/o la prevención de otitis e infecciones respiratorias de vías altas.
CONC2020/0009424A 2018-01-26 2020-07-29 Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas CO2020009424A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382046.3A EP3517119B1 (en) 2018-01-26 2018-01-26 Composition comprising new lactobacillus salivarius strain and method for the prevention and treatment of otitis and upper respiratory infections
PCT/EP2019/051858 WO2019145476A1 (en) 2018-01-26 2019-01-25 Composition comprising new lactobacillus salivarius strains and method for the prevention and treatment of otitis and upper respiratory infections

Publications (1)

Publication Number Publication Date
CO2020009424A2 true CO2020009424A2 (es) 2020-10-30

Family

ID=61189392

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2020/0009424A CO2020009424A2 (es) 2018-01-26 2020-07-29 Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas

Country Status (15)

Country Link
US (2) US11406674B2 (es)
EP (1) EP3517119B1 (es)
JP (1) JP2021511822A (es)
AU (1) AU2019211073A1 (es)
BR (1) BR112020015168A2 (es)
CA (1) CA3089366A1 (es)
CL (1) CL2020001958A1 (es)
CO (1) CO2020009424A2 (es)
DK (1) DK3517119T3 (es)
ES (1) ES2898876T3 (es)
MX (1) MX2020007906A (es)
PE (1) PE20210319A1 (es)
PT (1) PT3517119T (es)
RU (1) RU2020125713A (es)
WO (1) WO2019145476A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA99007378A (es) 1997-02-11 2005-04-19 Entpr Ireland Cepas probioticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de lasmismas.
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
DE60137235D1 (de) 2000-08-25 2009-02-12 Wakamoto Pharma Co Ltd L. salivarius-Stamm enthaltende probiotische Produkte
RU2302458C2 (ru) 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Пробиотический штамм lactobacillus salivarius (варианты), пробиотический препарат на их основе и способ лечения или предупреждения с использованием штаммов lactobacillus salivarius
PE20030274A1 (es) 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий
KR101098946B1 (ko) 2009-07-22 2011-12-28 대한민국 신규한 락토바실러스 살리바리우스 균주 및 이를 함유하는 사료첨가제 조성물
CN102618452B (zh) 2011-02-01 2014-06-25 任发政 唾液乳杆菌及其代谢物的制备方法和组合物以及应用
US9403181B2 (en) * 2013-07-26 2016-08-02 Paul O'Malley Oral care product formulation
WO2015093937A1 (en) 2013-12-19 2015-06-25 N.V. Nutricia Lactobacillus salivarius for the treatment of mastitis
CN104095224A (zh) * 2014-06-11 2014-10-15 胡安然 一种防治中耳炎的微生态特殊膳食
US20170333494A1 (en) 2014-11-10 2017-11-23 Glaxosmithkline Intellectual Property Development Limited Probiotic therapeutic applications

Also Published As

Publication number Publication date
CA3089366A1 (en) 2019-08-01
EP3517119B1 (en) 2021-08-11
PT3517119T (pt) 2021-11-30
CL2020001958A1 (es) 2020-12-11
MX2020007906A (es) 2020-10-28
AU2019211073A1 (en) 2020-08-20
DK3517119T3 (da) 2021-11-15
JP2021511822A (ja) 2021-05-13
WO2019145476A1 (en) 2019-08-01
RU2020125713A (ru) 2022-02-28
BR112020015168A2 (pt) 2020-12-29
US20210030820A1 (en) 2021-02-04
EP3517119A1 (en) 2019-07-31
ES2898876T3 (es) 2022-03-09
PE20210319A1 (es) 2021-02-16
US11406674B2 (en) 2022-08-09
US11903983B2 (en) 2024-02-20
US20220347240A1 (en) 2022-11-03
WO2019145476A8 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
MX2021000285A (es) Composiciones que comprenden cepas bacterianas.
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
PT3412766T (pt) Estirpe lactobacillus salivarius, composição que compreende a mesma e suas utilizações
CL2018000963A1 (es) Cosmética que tiene bacterias probióticas
AR101072A1 (es) Extracto de fermento de una cepa bacteriana para el aumento de los niveles de adiponectina
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
CL2018001936A1 (es) Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación.
SG10201910740UA (en) Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same
AU2016100865A4 (en) Multi-strain probiotic composition
GB201815025D0 (en) Insect-pathogenic fungus, spores, composition and use of same
WO2018135843A3 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
MX2021004150A (es) Composiciones que comprenden cepas bacterianas.
WO2017123610A3 (en) Bacteria engineered to detoxify deleterious molecules
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
CL2018001680A1 (es) Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
EP3620513A4 (en) COMPOSITION CONSISTING OF STRAINS CJLP475 OF LACTOBACILLUS PLANTARUM AND CJLP243 OF LACTOBACILLUS PLANTARUM, AND ASSOCIATED USE
CO2020009424A2 (es) Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas
AR101538A1 (es) Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden
MX2020001501A (es) Streptococcus australis como bioterapeuticos.
MX2018012312A (es) Lactobacillus rhamnosus para su uso en la preparacion de productos fermentados.
AR109026A1 (es) Composiciones que comprenden cepas bacterianas
AR104989A1 (es) Composiciones comprendiendo cepas bacterianas del genero blautia, producto alimenticio, composición de vacuna, método de tratamiento, célula y cultivo